INVO Bioscience, Inc. (INVO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 95.07M |
| Enterprise Value | 1.64B |
| P/E Ratio | -0.01 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.29 |
| Price/Book Ratio | 0.09 |
| Enterprise/Revenue | 0.48 |
| Enterprise/EBITDA | -1.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.41 |
| Operating Margin | -1.04 |
| Return On Assets | -1.15 |
| Return On Equity | -4.9 |
| Revenue | 6.84B |
| Revenue/Share | 14.33 |
| Gross Profit | 2.56B |
| EBITDA | -25.91M |
| Net Income | -25.13M |
| Diluted EPS | -214.64 |
| Total Cash | 4.9B |
| Total Cash/Share | 4.35 |
| Total Debt | 4.87B |
| Total Debt/Equity | 0.47 |
| Current Ratio | 0.27 |
| Book Value Per Share | 15.13 |
| 52-Week Change | -51.57 |
| 52-Week High | 3.5 |
| 52-Week Low | 0.63 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 0.9 |
| Average Volume | 1.15M |
| Shares Outstanding | 3.91M |
| % Held by Institutions | 0.84 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 28, 2023 |